Covid 19 Research using Clinical Trials (Home Page)
SARS-CoV2 serum antibody testingWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug183 | Anti-SARS-CoV-2 Human Convalescent Plasma Wiki | 1.00 |
Correlated MeSH Terms (2)
|
Name (Synonyms) |
Correlation |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The goal of this study is to understand the infectious exposure of SARS-coronavirus 2
(SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with
self-reported indices of COVID-19 illness.
NCT04389294 COVID Diagnostic Test: SARS-CoV2 serum antibody testing
Primary Outcomes
Measure: Correlation between serology testing and clinical suspicion of COVID-19 Time: Serology Test #1 (Study Enrollment)
Secondary Outcomes
Measure: Prevalence of SARS-CoV2 exposure Time: Serology Tests #1 and 2 (3 months apart)
Measure: Correlation of pre-existing risk factors with results of serology testing Time: Serology Test #1 (Study Enrollment)
Measure: Number of asymptomatic participants with positive antibody serology Time: Serology Test #1 (Study Enrollment)
Measure: Proportion of antibody- positive participants who subsequently develop COVID-19 Time: Serology Tests #1 (Study Enrollment) and Serology Test #2 (3 months apart)
Measure: Proportion of participants who are eligible for in plasma donation Time: Serology Tests #1 and 2 (3 months apart)
No related HPO nodes (Using clinical trials)